comparemela.com

Latest Breaking News On - Quarter for ligand pharmaceuticals - Page 1 : comparemela.com

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Stake Raised by Isthmus Partners LLC

Isthmus Partners LLC lifted its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 4.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,347 shares of the biotechnology company’s stock after purchasing an additional 1,530 shares during the period. Isthmus Partners […]

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Director Nancy Ryan Gray Sells 934 Shares

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) Director Nancy Ryan Gray sold 934 shares of the business’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $83.20, for a total value of $77,708.80. Following the completion of the transaction, the director now owns 5,633 shares in […]

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) CFO Octavio Espinoza Sells 5,873 Shares

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) CFO Octavio Espinoza sold 5,873 shares of the company’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $86.01, for a total value of $505,136.73. Following the completion of the transaction, the chief financial officer now directly owns 23,882 […]

Octavio Espinoza Sells 5,156 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Stock

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) CFO Octavio Espinoza sold 5,156 shares of the business’s stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $86.66, for a total transaction of $446,818.96. Following the sale, the chief financial officer now owns 23,379 shares of […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.